Are there existing examples where the FDA approved a drug and a patent infringement suit was successful shortly thereafter?
This has happened hundreds of times in cases where the suit was filed by the branded-drug company; what makes the MNTA-Amphastar case unusual is that one generic-drug company is suing another.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.